The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • The (sick) kids aren’t alright: Observations from a teacher with Long COVID

    The (sick) kids aren’t alright: Observations from a teacher with Long COVID

    Flynn Lovelace

    We must help students by addressing Long COVID and advocating for clean air in schools. Read more…

Recent articles

  • How to interpret clinical trial results for Long COVID
    Science
    Simon Spichak

    How to interpret clinical trial results for Long COVID

  • Research updates, July 21
    Science
    Miles W. Griffis

    Research updates, July 21

  • National COVID-19 trends, July 21
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, July 21

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersAbandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersWhitney Fox
What can professional athletes teach us about Long COVID and rest?What can professional athletes teach us about Long COVID and rest?Melanie Marich
How to interpret clinical trial results for Long COVIDHow to interpret clinical trial results for Long COVIDSimon Spichak
National COVID-19 trends, July 21National COVID-19 trends, July 21Betsy Ladyzhets
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis

Policy & Advocacy

Science

  • A purple background features a photo of Cochrane editor-in-chief Dr. Karla Soares-Weiser wearing a turtleneck and wool blazer. To her left, a screenshot of the controversial 2019 review called "Exercise therapy for chronic fatigue syndrome." On top of the review is a stamped black text box with white alphanumeric symbols indicating swear words.
    February 4, 2025

    “Really pissed off”: Cochrane receives backlash from advocates and experts after abandoning ME/CFS review

  • finger pointing to a brain scan
    February 4, 2025

    Research updates, February 4

  • This graphic includes a collage of Sen. Todd Young, Trump nominee RFK Jr., and a protestor wearing an N95 and holding a sign reading "LONG COVID DENIAL (does not equal) CURE"
    January 31, 2025

    RECOVER hasn’t been impacted by Trump freezes so far, sources say. But the program’s future is still uncertain.

  • test tubes in laboratory
    January 28, 2025

    Research updates, January 28

  • January 23, 2025

    Long COVID is a smoldering threat to wildland firefighters

  • This graphic shows two medical drawings of the human body, with icons of SARS-CoV-2 overlaid on top of different body parts to signify viral persistence.
    January 21, 2025

    Finding an accepted Long COVID biomarker will be complicated. This blood test could give us answers.

Previous Page
1 … 19 20 21 22 23 … 37
Next Page

Covid-19

  • September 3, 2024

    National COVID-19 trends, September 3

  • August 27, 2024

    National COVID-19 trends, August 27

  • August 21, 2024

    These are the drag artists and organizers fighting to make queer spaces more COVID safe

  • August 20, 2024

    Outdoor dining fades as pandemic persists — making public spaces even less accessible

  • Line chart showing national and regional trends of SARS-CoV-2 viral activity levels in wastewater. National levels (in black) have been trending up since May; the West Coast (teal) and South (purple) report equal or higher levels now than during the peak of last winter's surge.
    August 20, 2024

    National COVID-19 trends, August 20

  • Line chart, showing Covid-19-associated hospitalizations in California during the 2022-23 (green) and 2023-24 (red) "respiratory virus" seasons. Current hospitalizations, as of July 2024, are about twice as high as July 2023. Data last updated August 8, 2024.
    August 13, 2024

    National Covid-19 trends, August 13

Previous Page
1 … 19 20 21 22 23 … 30
Next Page

Health

Commentary

  • September 23, 2025

    Letter to the editors: Concerns about California’s right-to-mask bill

  • September 12, 2025

    Stop looking for a silver bullet. Start mixing the Long COVID cocktail.

  • A graphic showing white KN94 masks and yellow and white megaphones in a neat pattern that alternates the two objects. The background is a dark navy.
    September 2, 2025

    How do you get people to care about COVID-19? Here’s what I’ve learned as an organizer.

  • A portrait of Jermaine Greaves, repeated six times in a grid with alternating color tones, white and yellow
    August 15, 2025

    Long COVID taught me to slow down and stop trying to meet able-bodied benchmarks

Previous Page
1 … 7 8 9 10 11 … 26
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...